Polaryx Therapeutics, Inc. - PLYX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$5.827M
QoQ value delta ($000)
-$11.31M (-65.99%)
Implied price effect (QoQ)
-64.84%
Shares
Total shares
2,193,099
QoQ shares delta
-74,037 (-3.27%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (PLYX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
VANGUARD CAPITAL MANAGEMENT LLC 4,409 1,657,872 0.0%
GEODE CAPITAL MANAGEMENT, LLC 455 170,998 0.0%
VANGUARD FIDUCIARY TRUST CO 279 105,072 0.0%
HRT FINANCIAL LP 218 82,094 0.0%
STATE STREET CORP 154 58,104 0.0%
BlackRock, Inc. 109 41,012 0.0%
JANE STREET GROUP, LLC 83 31,441 0.0%
NORTHERN TRUST CORP 74 27,987 0.0%
Allworth Financial LP 20 7,727 0.0%
Vanguard Global Advisers, LLC 16 6,318 0.0%
Tower Research Capital LLC (TRC) 7 3,002 0.0%
UBS Group AG 3 1,283 0.0%
Fortitude Family Office, LLC 0 189 0.0%